SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-21-026984
Filing Date
2021-02-24
Accepted
2021-02-23 19:57:25
Documents
1
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a21-7712_1sc13da.htm SC 13D/A 75775
  Complete submission text file 0001104659-21-026984.txt   77426
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Filed by) CIK: 0001030617 (see all company filings)

Type: SC 13D/A

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 (301) 825 5320
Cellular Biomedicine Group, Inc. (Subject) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82437 | Film No.: 21667946
SIC: 2836 Biological Products, (No Diagnostic Substances)